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The distribution of cytosine methylation in 6.2 Mb of the mouse genome was tested using cohybridization of
genomic representations from a methylation-sensitive restriction enzyme and its methylation-insensitive isoschizomer.
This assay, termed HELP (HpaII tiny fragment Enrichment by Ligation-mediated PCR), allows both intragenomic
profiling and intergenomic comparisons of cytosine methylation. The intragenomic profile shows most of the
genome to be contiguous methylated sequence with occasional clusters of hypomethylated loci, usually but not
exclusively at promoters and CpG islands. Intergenomic comparison found marked differences in cytosine
methylation between spermatogenic and brain cells, identifying 223 new candidate tissue-specific differentially
methylated regions (T-DMRs). Bisulfite pyrosequencing confirmed the four candidates tested to be T-DMRs, while
quantitative RT-PCR for two genes with T-DMRs located at their promoters showed the HELP data to be correlated
with gene activity at these loci. The HELP assay is robust, quantitative, and accurate and is providing new insights
into the distribution and dynamic nature of cytosine methylation in the genome.
[Supplemental material is available online at www.genome.org.]
While cytosine methylation is a major component of epigenetic
regulation of gene expression, many of the techniques used to
test cytosine methylation at multiple loci are not suitable for
comparing methylation levels at different loci within a genome.
In contrast, analogous intragenomic profiling has been success-
fully developed for studying chromatin organization using chro-
matin immunoprecipitation with genomic microarrays (ChIP-
chip) (Kim et al. 2005) and DNA copy number using array com-
parative genomic hybridization (aCGH) (Selzer et al. 2005). The
establishment of a platform for intragenomic profiling is a pre-
requisite for integrating studies of cytosine methylation with
other whole-genome studies of epigenetic regulation. Compre-
hensive reviews of cytosine methylation analytical techniques
describe the various approaches used to date (Laird 2003; Ushi-
jima 2005), not including several recent reports of note (Ching et
al. 2005; Hu et al. 2005; Weber et al. 2005).
The use of restriction enzymes that are sensitive to cytosine
methylation has allowed many of the early insights into the dis-
tribution of methylated CpG dinucleotides in the mammalian
genome. For example, the use of HpaII revealed that most of the
genome remains high molecular weight following digestion de-
spite the short recognition motif (5-CCGG-3) at which the en-
zyme cuts (Singer et al. 1979). It was subsequently recognized
that 55%–70% of HpaII sites in animal genomes are methylated
at the central cytosine (Bird 1980; Bestor et al. 1984), which is
part of a CpG dinucleotide. The minority of genomic DNA that
cuts to a size of hundreds of base pairs was defined as HpaII Tiny
Fragments (HTFs) (Bird 1986), revealing a population of sites in
the genome at which two HpaII sites are close to each other and
both unmethylated on the same DNA molecule. Cloning and
sequencing of these HTFs revealed them to be (G+C)- and CpG
dinucleotide-rich, allowing base compositional criteria to be cre-
ated to predict presumably hypomethylated CpG islands
(Gardiner-Garden and Frommer 1987). These criteria remain in
use for genomic annotations today, defining sequences that tend
to localize with transcription start sites, especially of genes active
constitutively (Larsen et al. 1992) or during embryogenesis
(Ponger et al. 2001).
Genome sequencing project data have revealed that <12%
of HpaII sites in the human genome (and <9% in mouse) are
located within annotated CpG islands (Fazzari and Greally 2004).
This raised the question of whether a substantial proportion of
HTFs is, in fact, derived from non-CpG island sequences and
could be used to examine many non-CpG island sites in the
genome for cytosine methylation status. We describe a technique
that is based on HTF enrichment by ligation-mediated PCR, cre-
ating the acronym HELP that gives a name to this assay. We
demonstrate that the HELP enrichment, used as part of compara-
tive isoschizomer profiling and in combination with customized
genomic microarrays, allows robust intragenomic profiling of cy-
tosine methylation. We show that in primary mouse tissues
28%–34% of annotated CpG islands are categorized as methyl-
ated, that the technique reveals large numbers of tissue-specific
differentially methylated regions (T-DMRs), and that some of the
hypomethylated sites are located at repetitive sequences. These
surprising patterns of cytosine methylation indicate that the in-
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tragenomic profiling capability of the HELP assay will allow in-
sights into this major mediator of epigenetic regulation that were
not possible with single-locus studies or intergenomic compari-
sons.
Results
Prior techniques that sample the methylated fraction of the ge-
nome (Frigola et al. 2002; Yan et al. 2002; Chen et al. 2003) have
the disadvantage of generating a sample likely to be extremely
enriched in repetitive sequences (Yoder et al. 1997), making it
difficult to identify the genomic source of the sample using sub-
sequent hybridization or sequencing techniques. Furthermore,
the failure of one of these prior techniques to generate a repre-
sentation for a specific genomic region could be due to a genuine
difference in cytosine methylation, but it could also be due to a
technical failure, deletion of the region (a major issue when
studying cancer epigenetics), or base compositional differences
(absence of CpGs or suitable restriction sites). With the HELP
assay, an internal control allows these issues to be overcome.
While HpaII profiling on its own is subject to exactly the same
problems, a comparison between a HpaII profile and that of its
CpG methylation-insensitive isoschizomer MspI should over-
come these issues. The MspI profile can be considered to repre-
sent the total possible population of HTFs, of which the actual
HTFs constitute a sample. The use of an internal reference allows
every site from which HTFs originate to be analyzed in terms of
the relative amounts generated by the HpaII and the MspI rep-
resentations, creating a profile of cytosine methylation across the
genome.
To create these HpaII and MspI representations, we isolate
high molecular weight DNA, digest it to completion, and ligate
an oligonucleotide pair that creates an end cohesive with that
produced by the restriction enzymes. This serves as the template
for a PCR primer to perform ligation-mediated PCR (LM-PCR).
The PCR conditions create products ranging in size from 200 to
2000 bp (Fig. 1). The HpaII and MspI representations are labeled
with different fluorophores using random priming and cohybrid-
ized to a customized genomic microarray.
We designed the genomic microarray to represent some of
the diversity within the mouse genome, including autosomes
and sex chromosomes, constitutively active and tissue-specific
genes, regions we found to be CpG-depleted (the Y chromosome;
Fazzari and Greally 2004), CpG island-rich regions (Hox gene
clusters), and an imprinted locus (H19) (Table 1). The HpaII-
amplifiable fragments from these regions were identified in silico
as loci where two HpaII sites are located 200–2000 bp apart with
at least some unique sequence between them. Each HpaII-
amplifiable fragment was represented on the microarray by 10
oligonucleotides, each 50 nucleotides in length. A genome-wide
bioinformatic analysis was performed to ensure that each oligo-
nucleotide used was unique in the genome. In Supplemental Fig-
ure 1, we show that the range of sizes represented is as low as 200
bp and that the distribution of sizes in the genomic regions stud-
ied is skewed toward smaller fragments. The resolution of the
HELP assay is therefore in the range of hundreds of base pairs. A
total of 1339 sites representing the HpaII-amplifiable fragments
from ∼6.2 Mb of the mouse genome was represented on a micro-
array with >13,000 oligonucleotides.
The cell samples chosen for analysis were spermatogenic
cells and whole brains from young adult mice, since we had
generated preliminary data (not shown) revealing differences in
cytosine methylation at certain loci between these tissues. To
reduce the influences of genotype, sex, age, diet, or other envi-
ronmental influences on epigenetic organization, identically
housed male littermates were used for these experiments. To
measure the variability due to the experimental protocol alone,
digested DNA from one of the mice was subjected to three sepa-
rate experimental preparations.
Our first goal was to explore the sources of variability in the
assay. We represent these findings in two ways, by calculating
the mean and ranges of correlation coefficients for HpaII/MspI
log ratios (illustrated with representative scattergrams in Fig. 2)
and for HpaII and MspI individually (Supplemental Fig. 2A). We
also depict the same data by means of branching dendrograms
(Supplemental Fig. 2B). The amount of variability due to differ-
ences in cytosine methylation between tissues is greatly in excess
of the biological and experimental variability.
When we studied the microarray signal characteristics (Fig.
3A), we found that the median fluorescence intensity for each of
the 1339 loci varies as a function of the size of the HpaII frag-
Figure 1. Principle of the HELP assay. The HELP assay is based on a
comparison of representations from the genome following digestion by
HpaII or its methylation-insensitive isoschizomer MspI. The representa-
tions are limited to a size range of 200–2000 bp by the use of ligation-
mediated PCR. The MspI representation is the total potential population
of sites that could be generated by the HpaII representation were none of
these sites to be methylated. However, as 55%–70% of these sites are
methylated in animal genomes (Bird 1980; Bestor et al. 1984), the HpaII
representation will always represent a subset of the MspI representation.
By comparing the relative representation at individual loci, assignment
can be made of cytosine methylation status. While loci such as A should
be amplified in both the HpaII and MspI representations, the failure of
HpaII to digest both sites at loci B and C will yield a representation from
MspI alone, while the partial methylation depicted at locus D should
generate a lower HpaII/MspI ratio than at locus A. If a locus is deleted (or
has a sequence change at the enzyme cleavage sites) as shown at E,
neither representation will generate the locus.
Cytosine methylation analysis using the HELP assay
Genome Research 1047
www.genome.org
ment. This was the expected consequence of heterogeneity in
PCR amplification efficiency, resulting in differences in signal
intensities across the range of sizes represented for each isoschi-
zomer. However, it was also strikingly apparent that the HpaII
representation is distinctive for having a population of loci
throughout the size range that shows little signal. These loci re-
sult from the failure of the HpaII digestion to create a fragment
for PCR, the outcome expected for methylated loci. A frequency
histogram demonstrates this population, while a mixture model
allows us to categorize each locus in terms of where it falls within
this distribution of signal intensities. The category with the low-
est signal intensities allowed us to normalize signal intensities
across microarrays, as described in the Methods section.
Our starting hypothesis was that the comparison with MspI
would create a valuable internal control for our HpaII represen-
tation. When we create a HpaII/MspI log ratio density plot aver-
aged over the three biological replicates for each tissue (Fig. 3B),
we see that the distribution of values creates what resembles a
bimodal distribution. It is apparent that the majority of loci
tested falls into a group with little HpaII representation com-
pared with the MspI representation. This fits with the known
methylation of most HpaII sites in the genome (Bird 1980; Bestor
et al. 1984) and indicates a group of loci for which a methylated
status can be assigned with confidence. When we break down the
distribution by the categories of signal intensities that we ob-
served for the HpaII representation, we find that the peak of
lower ratio values is mostly generated by loci with low HpaII
signal intensities, with the peak of higher ratios generated by the
correspondingly higher HpaII signal intensities. The data indi-
cate a log ratio value of 0.15 to be a reasonable threshold for this
experiment, discriminating the majority methylated population
from the range of less methylated loci in each tissue. The pro-
portion of loci below this threshold is greater in spermatogenic
cells than in brain (72% vs. 65%).
The HpaII/MspI log ratio is plotted in Figure 4 as a function
of genomic position for each tissue in two representative regions.
We represent each locus in terms of its deviation from the 0.15
threshold value; loci with greater methylation generate a nega-
tive deflection, while relatively hypomethylated loci generate a
positive value. The intragenomic profiles of cytosine methyl-
ation in regions of chromosomes 7 and 17 are illustrated. Some
striking patterns are evident: The majority of the genome exists
as contiguous methylated blocks, interspersed by hypomethyl-
ated clusters that are mostly located at annotated transcription
start sites. Most but not all repetitive elements are methylated,
and there exist some hypomethylated sites that are located nei-
ther at promoters nor CpG islands.
The data not only reveal the intragenomic profile of cyto-
sine methylation, they also illustrate the intergenomic compari-
son that is possible. Some loci are clearly distinctive in terms of
cytosine methylation between brain and spermatogenic cells.
Such tissue-specific differentially methylated regions (T-DMRs)
have been identified by means of challenging techniques such as
RLGS, resulting in the publication of several hundred to date
(Shiota et al. 2002; Song et al. 2005); in this study, we demon-
strate that T-DMRs are frequent and not confined to gene pro-
moter regions.
We performed bisulfite pyrosequencing (Dupont et al.
2004) at four loci to validate the HELP results indicating differ-
ences in cytosine methylation between these tissues. Each was
chosen for a specific reason: two were located at promoters of
genes where we could perform correlative gene expression stud-
ies, and two represented the intriguing class of hypomethylated
loci that are located at intergenic, non-promoter, non-CpG is-
land sites. Of the latter, one is the region upstream of H19 known
to be methylated in spermatogenic cells and allele-specifically
methylated in somatic tissues (Davis et al. 1999). Other than this
locus, none of the others was previously recognized to exhibit
tissue-specific methylation. In Figure 5, we show these results
integrated with the HELP data and genomic annotations (avail-
able as custom tracks for the UCSC Genome Browser using the
links below). The HELP data indicating the site 5 to H19 to be
methylated in spermatogenic cells and relatively hypomethyl-
ated in brain were confirmed. The sites ∼20 kb upstream from
Pou5f1 (Oct3/4) showed the opposite pattern of methylation,
with relative hypomethylation in spermatogenic cells. The most
telomeric HpaII site is located within a B2 SINE but is only par-
tially methylated by bisulfite pyrosequencing in each tissue, con-
firming for this locus what is indicated to occur at multiple
loci using the HELP assay: A small proportion of interspersed
Table 1. Regions of mouse genome represented on microarray
Mouse May 2004
(mm5) assembly Chromosome Start End Size
Number of
CpG islands
Number of
promoters
Ube1Y1 region Y 45,000,000 46,500,000 1,500,000 0 10
Sphk1 locus 11 116,197,165 116,212,119 14,954 1 4
Nhp2l1 region Y 36,855,081 37,207,045 351,964 10 5
Pseudoautosomal region X/Y X 158,320,323 160,634,946 2,314,623 8 6
HoxD domain 2 74,289,189 74,837,588 548,399 23 12
Gata2 locus 6 88,508,149 88,591,788 83,639 4 2
Pou5f1 locus 17 33,960,379 34,075,826 115,447 2 7
HoxA domain 6 51,648,991 52,733,490 1,084,499 31 18
H19 imprinting transition region 7 130,120,718 130,298,950 178,232 1 6
Total 6,191,757 80 70
Represented on array 73 52
Proportion on array 91.25% 74.29%
Regions on the Y chromosome were included because of the CpG depletion we measured for this chromosome (Fazzari and Greally 2004); the
pseudoautosomal region was included as an area for which cytosine methylation has been observed during spermatogenesis (Bernardino et al. 2000);
the Hox clusters were included because of their CpG island enrichment and low repetitive DNA content; and the Sphk1, Gata2, and Pou5f1 loci were
included for having been found previously to have tissue-specific cytosine methylation at their promoters (Imamura et al. 2001; Gidekel and Bergman
2002; Song et al. 2005). The H19 locus was included for its well characterized cytosine methylation and its epigenetically distinctive property of genomic
imprinting.
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repetitive elements is hypomethylated in the genome (Supple-
mental Fig. 3). We tested to see whether the cytosine methyl-
ation results correlated with gene expression, choosing two loci
exhibiting differential methylation at gene promoters. In both
cases, we found that the methylation of these loci in spermato-
genic cells was associated with the near-complete silencing of
expression from each locus, while hypomethylation in brain was
associated with much higher levels of expression (Fig. 5; Supple-
mental Fig. 3). These results indicate that the HELP assay may
provide information that correlates with genome-wide gene ex-
pression data.
The validation studies allow us to correlate a number of
results from individual loci with the corresponding HpaII/MspI
log ratio values. The amount of HpaII product that can be formed
at a locus depends on the flanking HpaII site with the greater
amount of methylation, as both sites need to be digested to gen-
erate a template for PCR. This allows us to calculate the values
shown in Figure 5C, in which the proportional hypomethylation
is plotted against the HpaII/MspI log ratio. Those loci with log
ratios <0.15 are almost fully methylated, whereas those loci with
log ratios exceeding this threshold have methylation levels rang-
ing from 13% to 72%. With further
single-locus validation studies, we will
be able to test more rigorously whether
the HpaII/MspI log ratio predicts inter-
mediate degrees of cytosine methyl-
ation, as suggested by the current data.
T-DMRs in the context of these data
could be said to be ubiquitous, as no lo-
cus has identical HpaII/MspI ratios in
both tissues. However, the practical use
of this categorization is in defining loci
at which methylation is markedly differ-
ent between tissues. We could rank ev-
ery locus by the degree of divergence of
HpaII/MspI ratios, but a simple analysis
uses our threshold value of 0.15 to dis-
criminate loci that are likely to be highly
methylated from less methylated loci.
This categorization defines 223 T-DMRs,
167 of which are hypomethylated in
brain and methylated in spermatogenic
cells; the remainder (56 loci) show the
opposite pattern. As 223 represents one-
sixth of all of the loci on the microarray,
we can appreciate that T-DMRs are fre-
quent in the genome.
Because the validation studies
showed the HELP assay to be generating
reliable data, we performed data mining
of genomic sequence annotations from
the UCSC Genome Browser (Kent et al.
2002) to determine how the cytosine
methylation was distributed in the het-
erogeneous regions represented on the
microarray. We identified the loci repre-
sented on the microarray that had any
overlap with CpG islands and those
within 1.0 kb upstream of transcription
start sites of RefSeq genes. We also iden-
tified those loci on the microarray for
which one or both HpaII sites were lo-
cated within an annotated repetitive element. When we studied
the methylation categorization of each of these elements, we
found the results depicted in Table 2. Approximately 37%–41%
of the sites at promoters were in the methylated category, while
28%–41% of sites overlapping CpG islands were categorized in
the methylated category. In addition, the proportion of repeti-
tive elements classified as hypomethylated was 10%–12%, a
small minority of the total repetitive element content of the ge-
nome, but on a genomic scale potentially representing as many
as tens of thousands of hypomethylated repetitive sequences that
are of potential functional significance.
Discussion
This comparative isoschizomer profiling approach allows two
types of comparisons of cytosine methylation to be made. The
genomic DNA from two cell types can be compared (interge-
nomic comparison), revealing the presence of T-DMRs in this
study. Simultaneously, the intragenomic cytosine methylation
profile is generated for each cell type. The key to intragenomic
Figure 2. The variability due to tissue-specific differences in cytosine methylation greatly exceeds all
other sources of variability. We show the mean and range of correlation coefficients for all of the
experimental replicates (three independent HELP assays performed on DNA from a single mouse) and
biological replicates (three different mice) for the HpaII/MspI ratios. An illustrative scattergram is shown
for each situation. The variability involving HpaII/MspI representations across tissues greatly exceeds
any of the other sources of variability in the experimental system.
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comparisons is the use of an internal control to account for vari-
ables that would otherwise confound analysis. A difference in the
HpaII representation from two loci in the genome could be due
to a number of variables other than cytosine methylation. Chief
among these is base composition, since CpG dinucleotide and
HpaII site distributions are highly heterogeneous (Saccone et al.
Figure 3. (A) Microarray signal characteristics for MspI (black) and HpaII (red). The signal intensities mirror the relative amount of product across the
range of sizes in the PCR amplification. The HpaII representation shows the additional characteristic of a population of loci with low signal intensities,
likely to represent the more methylated loci in the sample. A mixture model applied to the distribution allows loci to be categorized according to their
relative signal intensities (center panel). (B) When the normalized mean HpaII/MspI log ratios are plotted as density histograms for each tissue, two
populations of loci are apparent: the majority have low ratios, with a minority falling into a higher distribution. The breakdown of the log ratios by HpaII
signal intensity category shows the low ratio peak to be mostly composed of those loci with lower HpaII signal intensities. In both tissues, a threshold
of ∼0.15 serves to distinguish these two distributions.
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1999). The internal control in the HELP assay is the MspI repre-
sentation, controlling for base composition, DNA copy number
(a major issue when studying cancer cells, in which amplifica-
tions and deletions are frequent [Lengauer et al. 1998]), and dif-
ficulty amplifying these frequently (G+C)-rich sites when gener-
ating the representations, which should affect the HpaII and
MspI representations for individual loci to comparable extents.
As the MspI representation remains relatively invariant in situa-
tions of differential methylation (for example, the brain and
spermatogenic cell comparisons of Fig. 2), the MspI representa-
tion provides a robust control with which to compare the HpaII
representation.
The HELP assay can be used on any genomic microarray and
with any combination of restriction enzyme isoschizomers dif-
fering in sensitivity to cytosine methylation of the target se-
quence. By using a customized oligonucleotide microarray, we
achieved the maximum resolution of 200 bp permitted by our
LM-PCR conditions. The HpaII/MspI isoschizomer pair allowed
most of the 82 CpG islands present in the genomic regions en-
compassed by the microarray to be represented (73 represented,
89.0%), and most of the 71 annotated RefSeq transcription start
sites, presumably representing true promoters, had HpaII-
amplifiable fragments within 1.0 kb upstream (52 represented,
73.2%). Unexpectedly, we found that a number of repetitive el-
ements were also represented using this unbiased design (4.2% of
the total number of repetitive elements in the regions studied).
The assay is readily scalable to the entire genome by expanding
the representation on customized microarrays. Our in silico
analysis demonstrates that the mouse genome has ∼600,000 loci
that can be tested using HELP, with a corresponding 750,000 loci
in the human genome. With sufficient microarray representa-
tion, the entire genome can be tested at once.
The number of techniques published for testing cytosine
methylation genome-wide is now sizable. This topic has been
extensively reviewed (Laird 2003; Ushijima 2005) prior to the
recent publication of several new approaches (Ching et al. 2005;
Hu et al. 2005; Weber et al. 2005). Each technique has clear
strengths and weaknesses, depending on the application. As
mentioned earlier, some techniques selectively enrich the meth-
ylated fraction of the genome (examples being differential meth-
ylation hybridization [DMH] [Yan et al. 2002] and methylated
DNA immunoprecipitation [meDIP] [Weber et al. 2005]), which
tends to enrich repetitive sequences, potentially causing difficul-
ties with hybridization-based approaches. Set against this con-
cern is the publication of successful outcomes of such experi-
ments (Paz et al. 2003; Keshet et al. 2006), indicating that the
problem is surmountable. Other techniques are inherently lim-
ited in terms of the number of loci that can be tested, including
RLGS and other techniques involving rare-cutting restriction en-
zymes (Ching et al. 2005). RLGS has the additional problem of
difficulty proceeding from the identification of a gel electropho-
resis difference to a genomic locus for validation studies, a prob-
lem to some extent addressed by virtual image RLGS (Matsuyama
et al. 2003). Base composition heterogeneity is another source of
intragenomic variability that is not usually addressed. If one re-
gion has many CG dinucleotides and another has very few, the
former region is likely to generate stronger signals indicating
methylation or its absence than the latter whatever their relative
methylation levels, especially with techniques that survey CG
dinucleotides in bulk, including affinity-based techniques such
Figure 4. Intragenomic profiling and intergenomic comparisons for two chromosomal regions. The HpaII/MspI log ratios are depicted in terms of their
deviation from the threshold value of 0.15. A downward deflection is indicative of a methylated locus, and an upward deflection is a relatively
hypomethylated locus. (Red) Brain cells, (green) spermatogenic cells. Transcription start sites are shared, CpG islands are represented (green rectangles),
and loci for which the fragment has one or both flanking HpaII sites located in a repetitive element are depicted (small triangle at the bottom of the
graph). (Black triangles) Methylated, (blue) hypomethylated in at least one of the tissues tested. (Orange) Loci subsequently tested by bisulfite
pyrosequencing. The red and green histograms are slightly shifted relative to each other for clarity. The intragenomic profile of cytosine methylation
shows that methylation is the predominant pattern in these regions, with short blocks of hypomethylation located mostly at promoters and CpG islands,
although some non-promoter, non-CpG island hypomethylation is also apparent. The intergenomic comparison between tissues shows overall con-
cordance but some clear tissue-specific differences, such as those at the orange arrowheads.
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as meDIP (Weber et al. 2005), the mcrBC-based cleavage of meth-
ylated DNA (Lippman et al. 2005), or methylation-sensitive re-
striction enzyme cocktails (Rollins et al. 2006; Schumacher et al.
2006). While these techniques are proving useful in inter-
genomic comparisons, normalization for base composition is
essential before they can be used for accurate intragenomic pro-
filing. Finally, the difficulty of validating results from these tech-
niques is generally inversely related to the number of sites they
survey. Techniques such as NotI profiling on BAC microarrays
(Ching et al. 2005) generate small numbers of defined sites for
analysis, whereas any technique that generates a signal based on
bulk CG dinucleotide surveys requires the investigator to test the
entire group of CGs in loci of interest. The HELP assay falls be-
tween the extremes, surveying fewer sites than the bulk tech-
niques but generating fewer sites for validation. The customized
microarray design means that the results obtained for each frag-
ment are individually independent of base composition. Base
composition affects the HELP assay only in terms of the density
of loci that can be tested, with more dense representation in
(G+C)-rich regions where the CCGG motif is more abundant.
The signals from individual HpaII-amplifiable fragments in
(G+C)-rich and -poor regions are otherwise directly comparable.
In addition, the use of a methylation-insensitive isoschizomer
controls for copy number, relative difficulty with PCR amplifica-
tion of different loci, and polymorphisms at the restriction en-
zyme cleavage site, as was demonstrated in a recent publication
(Hatada et al. 2006).
The HELP assay is technically quite straightforward and as-
sociated with very little experimental variability (Fig. 2; Supple-
mental Fig. 2). We identified 223 loci that are strong candidates
for being T-DMRs using the HELP assay, confirming the five can-
didates by testing using bisulfite pyrosequencing. Our cross-
correlation studies found a substantial proportion of sites anno-
tated as promoters or as CpG islands to be methylated, and a
minority of repetitive elements to be hypomethylated. The data
in Figure 4 suggest that hypomethylation is discretely organized
and restricted to small clusters within the genome that can ex-
tend into immediately flanking repetitive sequences. Any process
that is restricted in terms of its physical extent in the genome
should fail to involve most sequence features, including repeti-
tive elements. Whether these “hypomethylated islands” of DNA
non-randomly spare repetitive sequences or are influenced by
the base compositional criteria used in the definition of CpG
islands remains to be tested in a more extensive study.
An immediate disease-related application of genome-wide
cytosine methylation assays is to study cancer, in which epige-
netic regulation is profoundly disturbed (Jones and Baylin 2002).
The use of a methylation-insensitive isoschizomer controls for a
common variable in cancer, that of changes in copy number
(Lengauer et al. 1998). By reporting the ratio of isoschizomer
representations, amplified or deleted regions will generate a mea-
sure of cytosine methylation that can be used for intragenomic
comparisons with normal, diploid regions, making the HELP as-
say exceptionally suited to cancer epigenomic studies. However,
as we begin to recognize the role of epigenetics in other processes
and diseases, such as aging (Fraga et al. 2005), mediation of di-
etary influences (Wolff et al. 1998), and possibly the sequelae of
assisted reproductive technology (Maher et al. 2003), genome-
wide cytosine methylation assays are likely to find applications
beyond the cancer focus.
Methods
Sample preparation
C57Bl/6J male littermate mice were housed and fed identically
and sacrificed using humane techniques at ∼8 wk of age. DNA
was isolated from the whole brain and from the tubular contents
of the testes using proteinase K digestion, phenol-chloroform-
isoamyl alcohol extraction, dialysis against 0.2 SSC, and con-
centration by surrounding the dialysis bag with PEG 20,000 to
reduce water content by osmosis. The quality of the DNA was
checked by gel electrophoresis and spectrophotometry.
Isoschizomer representations
Ten micrograms of each DNA sample were digested to comple-
tion overnight using HpaII or MspI. The quality of digestion was
assessed using gel electrophoresis. The digested DNA was cleaned
by phenol-chloroform extraction, isopropanol-precipitated in
the presence of glycogen, and re-dissolved in TE pH 8.0. One-
tenth of the digested sample was added to T4 DNA ligase and the
following oligonucleotide pair:
5-CGACGTCGACTATCCATGAACAGC -3
3- GTACTTGTCGGC -5
The reaction mix was placed in a thermocycler for 5 min at
55°C then ramped over 1 h to 4°C, at which time 1 unit of T4
Table 2. Cross-correlation of HELP results with genomic
annotations
Methylated
in brain
Methylated in
spermatogenic cells
CpG island overlap 28.3% 34.2%
Promoter within 1000 bp 37.4% 41.1%
HpaII site in repetitive element 88.2% 90.1%
Substantial proportions of CpG islands and promoters fall into the meth-
ylated category, as defined by our threshold of a 0.15 centered HpaII/
MspI log ratio value. In addition, a minority of repetitive sequences falls
into the hypomethylated category, indicating that cytosine methylation
may have a more complex intragenomic distribution than previously be-
lieved.
Figure 5. Validation studies using bisulfite pyrosequencing. The H19 locus indicated by the orange arrowhead in Fig. 4 was tested for cytosine
methylation using bisulfite pyrosequencing of the original DNA samples used for the HELP assays. The samples from each of the three mice were tested
individually. The primary data are provided in Supplemental Table 1, and are represented here as the median value of the three generated. The figures
were generated by creating custom tracks for the UCSC Genome Browser and can be browsed in detail at http://greallylab.aecom.yu.edu/∼greally/
wiggle_tracks/HELP_data.htm. The degree of cytosine methylation is plotted as a percentage for spermatogenic cells (green) and brain (red). The HELP
data are shown for reference using the same color scheme. (A) The complete methylation of the HpaII sites at the H19 locus in spermatogenic cells is
consistent with the methylated categorization in the HELP assay and with prior studies of this region in spermatogenic cells (Davis et al. 1999). The
downstream HpaII site is more methylated in brain than the upstream site. As the proportion of molecules digested and available for amplification in
the HELP assay is dependent on the digestion of both flanking sites, the site with the greater degree of methylation determines this proportion. We
conclude that the 72.4% methylation of this site allowed the HELP representation categorized as hypomethylated. (B) The Hccs promoter shows clear
differences in cytosine methylation between tissues at all HpaII sites tested, with a corresponding change in gene expression levels. (C) Correlation of
all of the loci plotted by hypomethylation (bisulfite pyrosequencing data) against normalized HpaII/MspI ratios, with results from brain samples (red)
and spermatogenic cell samples (green) shown.
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DNA ligase was added for overnight ligation at 16°C. One of the
digested DNA samples from each mouse was divided into three
separate reactions to measure the amount of experimental vari-
ability. To perform LM-PCR, 1/50 of the MspI or 1/25 of the HpaII
sample was amplified using the 24-mer oligonucleotide shown
above. An initial extension for 10 min at 72°C filled in the 5
overhang, followed by 20 cycles of PCR using 30 sec at 95°C and
3 min at 72°C, with a final 10 min extension at 72°C. The quality
of the LM-PCR reaction was tested using gel electrophoresis,
looking for the size range of products shown in Figure 1, and the
product was cleaned using the Qiagen PCR purification kit and
quantified using spectrophotometry.
Microarray design and use
The microarrays were designed to represent loci amplified by the
LM-PCR reaction. The size range of product was 200–2000 bp
(Fig. 1), so an in silico digest was conducted with HpaII (CCGG),
and all sequence fragments of the appropriate size range were
retained. An initial probe set was generated by selecting a 50mer
oligo every 10 bp, avoiding repeat-masked regions and sequence
containing ambiguities. A measure of small oligo frequency was
determined by sliding a 15mer window along the length of each
50mer oligo and determining the average frequency. The unique-
ness of each 50mer was determined by looking for perfect
matches in the entire mouse genome using SSAHA2 (Ning et al.
2001). Ten 50mer oligonucleotides were selected to represent
each HpaII fragment using a score based selection algorithm
based on three primary parameters: average 15mer frequency,
50mer count, and base pair composition rules. The base pair
composition rules add penalties for homopolymer runs:
Stretches of more than three Gs or Cs, or more than five As or Ts,
are penalized, with larger penalties for longer stretches. After the
first oligo is selected, an additional positional parameter is added
to encourage uniform distribution of subsequent oligos along the
length of the fragment.
A microarray of ∼13,500 oligonucleotides was used to rep-
resent the ∼6.2 Mb of the mouse genome in this study. These
were printed using maskless array synthesis (Nuwaysir et al.
2002) in the NimbleScreen 12 format (NimbleGen Systems Inc).
The LM-PCR products were labeled for microarray analysis as
previously described (Selzer et al. 2005) using Cy3 or Cy5-
conjugated oligonucleotides and random primers. The HpaII and
MspI representations were cohybridized to the microarray in the
NimbleGen Service Laboratory and scanned to quantify the 532
and 635 nm fluorescence at each oligonucleotide on the micro-
array.
Data analysis
Each cohybridization was analyzed by visual inspection of the
image file to ensure that the signals were uniform. Each fragment
represented on the microarray consists of 10 separate oligo-
nucleotide probes, each with an associated signal intensity. We
calculated the median signal intensity for each fragment to de-
fine the fragment’s signal intensity. The HpaII and MspI signal
intensities were correlated and plotted against each other or frag-
ment length using the R statistical package (http://www.r-
project.org/) to generate the data in Figures 2 and 3. The branch-
ing dendrograms of Supplemental Figure 2 were generated based
on an epigenomic distance measurement of (1  correlation co-
efficient) and plotted using MatLab. The frequencies of loci with
different HpaII signal intensities were modeled using a mixed
Gaussian model (one variant) to separate loci into groups with
90% or 10% probabilities of being in the group of low intensity
signals, defining categories 1 and 2 in Figure 3; the remainder of
the loci with higher signal intensities were categorized as group
3. The range of intensities for group 1 was used as a measure of
variability between arrays. Normalization was performed by sub-
tracting the mean log ratio of this group of signal intensities in
order to center log ratios over the entire array. The normalized
HpaII/MspI log ratios for the three biological replicates in one
array were used to generate the data in Figures 3 and 4.
Validation studies using bisulfite pyrosequencing
Four loci showing tissue-specific cytosine methylation were cho-
sen for validation studies. The chromosome 7 sequence 5 to H19
appeared to be methylated in spermatogenic cells and hypo-
methylated in brain, while a site 20 kb 5 to Pou5f1 had the
opposite pattern, as did an immediately adjacent site represent-
ing a HpaII site present in a B2 SINE. Two promoter sequences
also exhibited differential methylation, at the Hccs and the
5730596B20Rik loci. We used a technique published for micro-
dissected cells (Kerjean et al. 2001) for bisulfite conversion, di-
gesting DNA from the same brain and spermatogenic cell samples
used for the HELP assay overnight, denaturing the DNA using
heat and NaOH, and embedding it in agarose beads. The DNA
was then treated with sodium bisulfite for 4 h at 50°C and then
washed in TE pH 8.0, followed by desulfonation with 0.2 M
NaOH. The beads were dialyzed in water prior to amplification
using PCR. The PCR and pyrosequencing primers were designed
using Biotage’s proprietary software. Amplification using the
primer pairs specific for each HpaII site was performed. Pyrose-
quencing was performed in a shared resource at this institution,
performing the assays on the three samples of DNA from differ-
ent animals. The primer sequences for each of these loci are
shown in Supplemental Table 2.
Quantitative analysis of gene expression
RNA was extracted from the same tissues used for the HELP assays
and analyzed for quality and concentration using electrophoresis
and spectrophotometry using Nanodrop (NanoDrop Technolo-
gies). RT-PCR primers were designed (primer sequences in
Supplemental Table 2) for quantitative PCR using SYBR Green
(SYBR Green PCR Master mix, Applied Biosystems) and the DNA
Engine OPTICON 2 (BioRad). As well as oligo-dT, gene-specific
primers were used for reverse transcription given the location of
5730596B20Rik within an intron of Hoxa3. We were concerned
that the analysis might be influenced by amplification of the
unprocessed Hoxa3 transcript, but we found near-identical re-
sults for both reverse transcription primers (not shown). Neither
Gapdh nor Hprt was suitable as a control locus, as each is sub-
stantially silenced in spermatogenic cells. However, the more ro-
bust approach in this case was to calculate relative levels of ex-
pression (mean of triplicate C(t) values) as a simple function of
RNA concentration to generate the data in Figure 5.
Mining and analysis of genomic sequence annotations
Genome sequence annotations were mined from the mm5 ver-
sion of the mouse genome at the UCSC Genome Browser (NCBI
build 33, http://genome.ucsc.edu/), the same database used to
design the microarrays. The coordinates for CpG islands, tran-
scription start sites of RefSeq genes, and repetitive elements were
downloaded for the genomic regions represented. Perl scripts
were used to identify the colocalization of loci on the microarray
with these genomic sequence features.
Fluorescence in situ hybridization
The MspI LM-PCR product was labeled by nick translation and
hybridized to a normal mouse metaphase, with fluorophores im-
Khulan et al.
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aged separately by fluorescence microscopy and merged using
Photoshop (Adobe).
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